Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways (Q38820034)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2015

Language	Label	Description	Also known as
English	Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways	scientific article published on 12 November 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Li-Ming Lien

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Meng-Jiy Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ray-Jade Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Hou-Chang Chiu

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jia-Lun Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ming-Yi Shen

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Duen-Suey Chou

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Joen-Rong Sheu

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Kuan-Hung Lin

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wan-Jung Lu

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

12 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Phytotherapy Research

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

214-221

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Synergistic anti-inflammatory effects of nobiletin and sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

The WHO classification of tumors of the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

G1 cell-cycle control and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Flavonoid composition of fruit tissues of citrus species

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

The challenges and the promise of molecular targeted therapy in malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

A highly invasive human glioblastoma pre-clinical model for testing therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Citrus nobiletin ameliorates experimental colitis by reducing inflammation and restoring impaired intestinal barrier function.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5517

21 January 2018

The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.3892/IJO.2015.2946

Identifiers

10.1002/PTR.5517

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

release_efkxfl365nfjvl2wr3vyqva2dq

1 reference

https://api.fatcat.wiki/v0/release/efkxfl365nfjvl2wr3vyqva2dq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38820034&oldid=2164750091"